focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUMM.L Share News (SUMM)

  • There is currently no data for SUMM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 18th Nov 2013 08:10

AGA Rangemaster: N+1 Singer raises its target price from 150p to 175p and keeps a buy recommendation.APR Energy: Jefferies cuts target price from 1300p to 1260p retaining a buy recommendation.Atkins (WS): LIberum Capital increases target price from 1300p to 1400p maintaining a buy recommendation.Aveva: Panmure Gordon ups target price from 2374p to 2386p and keeps a hold recommendation.Bank of Georgia: Panmure Gordon raises target price from 2200p to 3000p and retains a buy recommendation.Big Yellow Group: Numis raises target price from 460p to 535p keeping an add rating.Cairn Energy: UBS moves target price from 310p to 305p and stays with its buy recommendation.Cape: JP Morgan lowers target price from 299p to 288p and maintains a neutral rating.Carr's Milling: Investec increases target price from 1710p to 1900p and maintains a buy recommendation.Diploma: Jefferies takes target price from 720p to 750p and reiterates a buy recommendation. Numis downgrades from add to hold with a target price of 697p.Drax Group: Liberum Capital raises target price from 640p to 735p upgrading to buy.Euromoney: Investec ups target price from 1200p to 1250p and reiterates a buy recommendation.Foxtons: Canaccord Genuity upgrades to buy woth a target price of 320p.Gem Diamonds: JP Morgan moves target price from 180p to 185p retaining an overweight rating.International Consolidated Airlines Group: Nomura takes target price from 335p to 380p and keeps a buy recommendation.ITE Group: Investec places its target price (prev.: 335p) under review, while keeping its buy recommendation.Lancashire Holdings: Numis raises target price from 865p to 935p and upgrades from hold to add.Lonmin: Investec ups target price from 266p to 287p, but still recommends selling.Majestic Wine: Investec raises target price from 495p to 620p and retains a buy recommendation. Panmure Gordon increases target price from 500p to 635p and stays with its buy recommendation.MITIE Group: Investec ups target price from 310p to 330p and keeps a buy recommendation.New World Resources: Jefferies shifts target price from 70p to 75p and maintains its hold recommendation.Northern Petroleum: Westhouse Securities shifts target price from 123p to 120p, while upgrading to buy.Ocean Wilson Holdings: Cantor Fitzgerald ups target price from 1345p to 1400p and stays with its buy recommendation.Ophir Energy: Canaccord Genuity ups target price from 375p to 400p and retains a hold recommendation.Partnership Assurance: Deutsche Bank reduces target price from 470p to 385p keeping a hold recommendation.SAB Miller: JP Morgan increases target price from 3270p to 3465p and leaves its overweight rating unchanged.Shire: Jefferies raises target price from 3100p to 3400p and keeps a buy recommendation.Summit Corporation: N+1 Singer moves target price from 11p to 16.3p and reiterates a buy recommendation.Ultra Electronics: UBS cuts target price from 1900p to 1820p maintaining a neutral rating. JP Morgan reduces target price from 2100p to 1920p leaving its neutral rating unaltered.Vedanta Resources: Deutsche Bank cuts target price from 1050p to 1020p retaining a hold recommendation. Credit Suisse reduces target price from 1350p to 1270p and leaves its outperform rating unaltered.Volex Group: FinnCap upgrades to hold with a target price of 90p.
More News
11 Jun 2015 12:28

Summit Therapeutics first-quarter pre-tax loss widens

Drug discovery and development company Summit Therapeutics posted a 52.6% widening in its first-quarter pre-tax loss, pointing to the cost of listing on the NASDAQ and higher research and development costs. The pre-tax losses came in at $5.8m compared with $3.8m in the same period last year. In the

Read more
11 Jun 2015 11:25

Summit Therapeutics First Quarter Loss Widens On Higher Costs

Read more
20 May 2015 19:18

BUZZ-Sarepta news lifts other muscular distrophy stocks

** Companies developing muscular distrophy treatments, PTC Therapeutics and Summit Therapeutics had their shares boosted on Wednesday by positive regulatory news from a third firm in the same space, Sarepta Therapeutics ** PTC shares rose as much as 7.2 percent during the session and were

Read more
30 Mar 2015 12:15

Port Erin Biopharma Swings To First Half Loss As Gains Do Not Recur

Read more
5 Mar 2015 15:15

BUZZ-Summit Therapeutics Plc: Shares rise in debut

** Biopharmaceutical company's U.S.-listed shares up 2.7 pct at $10.20 ** Stock rises as much as 4.5 pct to $10.35, valuing company at $120.8 mln ** Offering of 3.45 American depository shares priced at $9.90 each ** IPO raised about $34.15 mln

Read more
19 Feb 2015 08:34

UK MORNING BRIEFING: Centrica Shares Fall 7.7% On Loss, Dividend Cut

Read more
19 Feb 2015 06:23

UK AGM, EGM Calendar - Week Ahead

Read more
18 Feb 2015 16:21

UK AGM, EGM Calendar - Week Ahead

Read more
18 Feb 2015 06:16

UK AGM, EGM Calendar - Week Ahead

Read more
17 Feb 2015 16:08

UK AGM, EGM Calendar - Week Ahead

Read more
17 Feb 2015 06:16

UK AGM, EGM Calendar - Week Ahead

Read more
16 Feb 2015 16:02

UK AGM, EGM Calendar - Week Ahead

Read more
16 Feb 2015 06:16

UK AGM, EGM Calendar - Week Ahead

Read more
13 Feb 2015 15:58

UK AGM, EGM Calendar - Week Ahead

Read more
13 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.